An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP

Elsa Irving1, Alaide Morcavallo1, Jekaterina Vohhodina-Tretjakova1

  • 1Bioscience, Oncology Targeted Discovery, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK.

Cancers
|January 28, 2026
PubMed
Abstract

Insights

A BRCA1 variant, ∆exon11, confers partial resistance to PARPi by restoring homologous recombination repair (HRR). Combining PARPi with ATR inhibitors overcomes this resistance, offering a new therapeutic strategy for BRCA1-mutant cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Poly(ADP-ribose) polymerase inhibitors (PARPi) are effective against homologous recombination repair (HRR) deficient cancers, particularly those with BRCA1/2 mutations.
  • Therapeutic resistance to PARPi is a significant clinical challenge.
  • The role of BRCA1 hypomorphic variants in PARPi resistance is not well understood.

Purpose of the Study:

  • To investigate the impact of distinct BRCA1 hypomorphic variants on PARPi sensitivity.
  • To elucidate the mechanism of resistance mediated by the ∆exon11 BRCA1 variant.
  • To identify potential combination therapies to overcome PARPi resistance.

Main Methods:

  • Engineered a doxycycline-inducible BRCA1 expression system in a BRCA1-mutant triple-negative breast cancer cell line (MDAMB436).
  • Assessed the in vitro and in vivo effects of various BRCA1 variants, including ∆exon11, on drug sensitivity and HRR.
  • Measured HRR restoration by RAD51 foci formation and interaction with repair partners like PALB2.
  • Evaluated the efficacy of combining olaparib with the ATR inhibitor ceralasertib.

Main Results:

  • Overexpression of the ∆exon11 BRCA1 hypomorph conferred resistance to olaparib and carboplatin in a dose-dependent manner.
  • ∆exon11 BRCA1 partially restored HRR, but less efficiently than full-length BRCA1, evidenced by reduced RAD51 foci and PALB2 interaction.
  • Tumors expressing ∆exon11 BRCA1 showed only partial resistance to olaparib in vivo.
  • The combination of olaparib and ceralasertib effectively overcame ∆exon11-mediated resistance and impaired RAD51 foci formation.

Conclusions:

  • The ∆exon11 BRCA1 hypomorph mediates a dose-dependent, partial restoration of HRR, explaining variable PARPi resistance in preclinical models.
  • ATR inhibition combined with PARPi represents a promising clinical strategy to counteract resistance driven by ∆exon11 BRCA1 hypomorphs.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Induced Electric Fields: Applications01:27

Induced Electric Fields: Applications

An important distinction exists between the electric field induced by a changing magnetic field and the electrostatic field produced by a fixed charge distribution. Specifically, the induced electric field is nonconservative because it does not work in moving a charge over a closed path. In contrast, the electrostatic field is conservative and does no net work over a closed path. Hence, electric potential can be associated with the electrostatic field but not the induced field. The following...
2.6K
Attenuated Total Reflectance (ATR) Infrared Spectroscopy: Overview01:13

Attenuated Total Reflectance (ATR) Infrared Spectroscopy: Overview

Attenuated total reflectance (ATR) infrared spectroscopy is a powerful analytical technique used to study the composition of materials. It is widely employed in chemistry, materials science, forensic science, and other fields where sample characterization is required. ATR has several advantages over traditional transmission IR spectroscopy, including the requirement of little to no sample preparation and the ability to analyze a wide range of samples.
The ATR process begins by directing a beam...
1.2K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
208